Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy.
See more here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy. The company told a Food and Drug Administration advisory committee in December 2008 that it would explore that potential use of the drug.
See the rest here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
Policy & Practice
Can’t get enough Policy & Practice? Check out our new podcast each Monday
Read more:
Policy & Practice
Epione Beverly Hills- Treatment For Sun Damaged Skin
- Breast Plastic Surgery – Symmetry, Form and Beauty
- Facial Acne Scars: Erasing The Marks Of Your Youth
- Danielle Staub from the Real Housewives of New Jersey receives Botox treatment at Epione Beverly Hills
- Do You Hate Your Acne Scars?
- The return of perfect skin
- Would You Like To Get Fuller Lips?
- Facial Wrinkle Removal: Getting Rid Of Facial Wrinkles
- Acne Scars: Information About Reducing The Appearance Of Acne Scars
- Cellulite Removal: Know The Facts